Caas Capital Management »

Cyteir Therapeutics shares owned by Caas Capital Management

Quarter-by-quarter ownership of Cyteir Therapeutics shares owned by Caas Capital Management from 13F filings

Historical chart of Caas Capital Management investment in Cyteir Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cyteir Therapeutics held by Caas Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cyteir Therapeutics by Caas Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $80k 26k 3.04
2023-09-30 $74k 26k 2.84
2023-06-30 $90k 35k 2.60
2023-03-31 $274k 150k 1.82
2022-12-31 $759k 460k 1.65
2022-09-30 $1.3M 617k 2.06
2022-06-30 $239k 80k 2.99
2022-03-31 $396k 105k 3.77
2021-12-31 $5.4M 478k 11.37
2021-09-30 $10M 580k 17.55
2021-06-30 $11M 500k 21.40